CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Yu Jung Kim, Sae-Won Han, Eunyoung Kang, Eun-Kyu Kim, Kidong Kim, Jae Hong No, Wonshik Han, Dong-Young Noh, Maria Lee, Hee Seung Kim, Seock-Ah Im, Jee Hyun Kim
Cancer Research and Treatment. 2017;49(4):1153-1163.   Published online 2017 February 27    DOI: https://doi.org/10.4143/crt.2016.463

Excel Download

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Cancer Research and Treatment. 2017;49(4):1153-1163   Crossref logo
Link1 Link2 Link3

Luteinizing Hormone-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Breast Cancer
Clinical Breast Cancer. 2007;7(6):455-464   Crossref logo
Link1 Link2

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials
Breast Diseases: A Year Book Quarterly. 2008;19(1):85   Crossref logo
Link1 Link2

Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer
European Journal of Cancer. 2010;46(16):2867-2869   Crossref logo
Link1 Link2

Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor–Positive Breast Cancer: A Global Treatment Option
Clinical Breast Cancer. 2016;16(4):233-237   Crossref logo
Link1 Link2

The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors
The Breast. 2010;19(2):149   Crossref logo
Link1 Link2

PR86 RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS
The Breast. 2015;24:S51   Crossref logo
Link1 Link2

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials
The Lancet. 2007;369(9574):1711-1723   Crossref logo
Link1 Link2

Underserved Premenopausal Women with Hormone Receptor Positive Breast Cancer Referred for Bilateral Salpingo-Oophorectomy – Is There a Benefit?
Journal of Minimally Invasive Gynecology. 2016;23(7):S85   Crossref logo
Link1 Link2

TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
The Lancet. 1982;319(8283):1213-1216   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.